A groundbreaking shift in Canadian drug policy has taken place, as the regulators allow the availability of psilocybin fungi for therapeutic purposes. Until now, these substances were severely restricted, but a increasing body of evidence suggests they potentially offer aid for emotional issues like PTSD. The new policy represents a substantial ste